Disposition of 492 shares by Joseph LaRosa of Regeneron Pharmaceuticals at 787.0 subject to Rule 16b-3
| GGEZX Fund | USD 27.59 0.14 0.50% |
Slightly above 62% of Growth Equity's investor base is looking to short. The analysis of overall sentiment of trading Growth Equity Investor mutual fund suggests that many investors are alarmed at this time. Growth Equity's investing sentiment can be driven by a variety of factors including economic data, Growth Equity's earnings reports, geopolitical events, and overall market trends.
Growth |
Filed transaction by Regeneron Pharmaceuticals Officer: Evp General Counsel And Secret. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at gurufocus.com
 |
Growth Equity Fundamental Analysis
We analyze Growth Equity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Growth Equity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Growth Equity based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
Growth Equity is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
Growth Equity Investor Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Growth Equity mutual fund to make a market-neutral strategy. Peer analysis of Growth Equity could also be used in its relative valuation, which is a method of valuing Growth Equity by comparing valuation metrics with similar companies.
Peers
Growth Equity Related Equities
| BUFHX | Buffalo High | 0.09 |
| ||
| ARTFX | Artisan High | 0.11 |
| ||
| SHYIX | Guggenheim High | 0.12 |
| ||
| SGYAX | Siit High | 0.14 |
| ||
| JHYAX | Janus High | 0.14 |
| ||
| JYHRX | Jpmorgan High | 0.15 |
| ||
| GMOZX | Gmo High | 0.17 |
|
Other Information on Investing in Growth Mutual Fund
Growth Equity financial ratios help investors to determine whether Growth Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Growth with respect to the benefits of owning Growth Equity security.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |